Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.

Alexandre Sepriano Andreas KerschbaumerJosef S SmolenDésirée Mfm van der HeijdeMaxime DougadosRonald van VollenhovenIain B McInnesJohannes W BijlsmaGerd R BurmesterMaarten P T de WitLouise FalzonRobert Landewé

Published in: Annals of the rheumatic diseases (2020)

Data obtained by this SLR confirm the known safety profile of bDMARDs. The risk of VTE in RA, especially in patients on JAK inhibitors, needs further evaluation.

Keyphrases

rheumatoid arthritis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
disease activity
venous thromboembolism
prognostic factors
peritoneal dialysis
rheumatoid arthritis patients
interstitial lung disease
systemic sclerosis
data analysis
deep learning
artificial intelligence